The Health Canada licensed 51,000 sq. foot manufacturing facility is located in Winnipeg, Manitoba. Source: Agraflora
  • AgraFlora Organics has completed the first phase of R&D trials at its automated edibles manufacturing facility
  • The Health Canada licensed 51,000 sq. foot manufacturing facility is located in Winnipeg, Manitoba
  • The company has created efficient processes for desired formulations and product varieties and expects to enter the edibles market in Q1 of 2021
  • The company said its edibles facility will utilize its current state of the art laboratory set-up to produce approximately 60,000 pieces per eight-hour shift
  • AgraFlora is up 40 per cent to C$0.035 per share

AgraFlora (AGRA) Organics has completed the first phase of R&D trials at its automated edibles manufacturing facility.

The Health Canada licensed 51,000 square-foot manufacturing facility is located in Winnipeg, Manitoba.

Prior to receiving a standard processing license from Health Canada, AgraFlora started cultivating long-term production relationships through Research and Development trials utilizing the company’s Health Canada R&D license.

The development phase of the R&D trials is now complete and the company has created efficient processes for desired formulations and product varieties and expects to enter the edibles market in the first quarter of 2021.

James Fletcher, Edibles and Infusions Corporation (AgraFlora’s subsidiary) Co-Founder and Operational Manager, said supply contracts continue to move forward with the company’s Licensed Producer relationships.

“We are confident that our gummies with consistent and flavourful variants will soon dominate the gummies category. Our family’s 97 years of confectionary experience provides us a solid culture of quality, craftmanship and efficiency to offer a variety of infused gummy products to multiple LP clients at a time,” he said.

Edibles and Infusions Corporation is a joint venture formed between AgraFlora and one of North America’s leading confectionary manufacturing families.

The company said its edibles facility will utilize its current state of the art laboratory set-up to produce approximately 60,000 pieces per eight-hour shift and can manage a variety of brands at once given the efficient nature of the automated production line.

The facility’s equipment and design allow Edibles and Infusions Corporation to easily pivot and provide specific dosing and custom gummies that meet regulatory requirements and customer specifications. These efficiencies also allow AgraFlora to produce saleable products at a lower cost.

AgraFlora is up 40 per cent to C$0.035 per share at 1:14pm EST.

More From The Market Online

Greenway Cannabis notches global cannabis accreditation

Greenway Greenhouse Cannabis (CSE:GWA) receives CUMCS-G.A.P and GACP certification for its cultivation facility in Ontario.

The Market Online’s Weekly Cannabis Report – April 26, 2024

Tilray has been garnering attention lately. Its subsidiary, Montauk Brewing Company, announced the return of Project 4:20 India Pale Ale

Buzz on the Bullboards: A recap of recent activity and stocks in focus

After a major sell-off, stock markets have been on edge, monitoring corporate earnings to gauge the direction of the economy.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.